See more : Artis Real Estate Investment Trust (AX-UN.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Chemclin Diagnostics Co., Ltd. (688468.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chemclin Diagnostics Co., Ltd., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Schmitt Industries, Inc. (SMIT) Income Statement Analysis – Financial Results
- EVA Airways Corp. (2618.TW) Income Statement Analysis – Financial Results
- The Trade Desk, Inc. (TTD) Income Statement Analysis – Financial Results
- Poongsan Corporation (103140.KS) Income Statement Analysis – Financial Results
- South Bow Corporation (SOBO) Income Statement Analysis – Financial Results
Chemclin Diagnostics Co., Ltd. (688468.SS)
About Chemclin Diagnostics Co., Ltd.
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic testing reagents and instruments. Its products include LiCA series of diagnostic reagents based on photoinduced chemiluminescence method, and CC series diagnostic reagents and instruments based on enzymatic chemiluminescence method for primarily used in infectious diseases markers, tumor markers, thyroid hormones, reproduction detection of endocrine hormones, myocardial markers, and inflammation. The company was founded in 2007 and is based in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 445.34M | 465.27M | 470.77M | 418.20M | 454.67M | 366.06M | 318.60M |
| Cost of Revenue | 109.72M | 119.26M | 118.38M | 115.20M | 113.75M | 97.80M | 88.62M |
| Gross Profit | 335.62M | 346.01M | 352.39M | 303.00M | 340.92M | 268.26M | 229.98M |
| Gross Profit Ratio | 75.36% | 74.37% | 74.85% | 72.45% | 74.98% | 73.28% | 72.18% |
| Research & Development | 65.77M | 68.89M | 67.32M | 56.42M | 56.45M | 50.92M | 32.24M |
| General & Administrative | 10.97M | 17.14M | 14.87M | 18.48M | 15.20M | 531.75M | 535.53M |
| Selling & Marketing | 42.20M | 94.66M | 104.40M | 89.78M | 105.34M | 81.45M | 65.21M |
| SG&A | 107.10M | 111.80M | 119.27M | 108.27M | 120.54M | 613.20M | 600.74M |
| Other Expenses | -3.53M | 16.59M | 18.22M | 12.50M | 14.92M | -899.86K | -106.23K |
| Operating Expenses | 168.50M | 197.28M | 204.81M | 177.19M | 191.91M | 685.60M | 655.48M |
| Cost & Expenses | 279.05M | 316.54M | 323.19M | 292.39M | 305.66M | 783.40M | 744.10M |
| Interest Income | 7.27M | 5.45M | 5.69M | 1.91M | 1.03M | 620.78K | 2.08M |
| Interest Expense | 618.99K | 518.69K | 730.06K | 7.66K | 6.23K | 47.62K | 41.82K |
| Depreciation & Amortization | 52.60M | 54.27M | 57.04M | 48.05M | 46.97M | 42.88M | 41.47M |
| EBITDA | 219.34M | 232.24M | 220.02M | 183.57M | 206.68M | -373.90M | -385.38M |
| EBITDA Ratio | 49.25% | 49.94% | 46.36% | 43.08% | 44.27% | -102.14% | -120.96% |
| Operating Income | 166.29M | 170.29M | 162.58M | 136.85M | 159.73M | -412.41M | -420.25M |
| Operating Income Ratio | 37.34% | 36.60% | 34.53% | 32.72% | 35.13% | -112.66% | -131.90% |
| Total Other Income/Expenses | -166.38K | 7.08M | -391.15K | -1.42M | -89.06K | -899.86K | -106.23K |
| Income Before Tax | 166.12M | 177.37M | 162.19M | 135.44M | 159.64M | -413.31M | -420.36M |
| Income Before Tax Ratio | 37.30% | 38.12% | 34.45% | 32.39% | 35.11% | -112.91% | -131.94% |
| Income Tax Expense | 18.75M | 24.74M | 19.43M | 18.42M | 19.05M | 10.94M | 14.87M |
| Net Income | 147.37M | 152.63M | 142.76M | 117.02M | 140.59M | -424.25M | -435.23M |
| Net Income Ratio | 33.09% | 32.80% | 30.32% | 27.98% | 30.92% | -115.90% | -136.61% |
| EPS | 0.37 | 0.38 | 0.36 | 0.29 | 0.35 | -2.11 | -2.17 |
| EPS Diluted | 0.37 | 0.38 | 0.36 | 0.29 | 0.35 | -2.11 | -2.17 |
| Weighted Avg Shares Out | 398.31M | 401.00M | 401.00M | 401.00M | 401.00M | 200.85M | 200.85M |
| Weighted Avg Shares Out (Dil) | 398.31M | 401.00M | 401.00M | 401.00M | 401.00M | 200.85M | 200.85M |
Source: https://incomestatements.info
Category: Stock Reports